Tizanidine
NDC 76420-338, Tizanidine, tablet, from Asclemed USA, Inc..
- Product NDC
- 76420-338
- Status
- Listed
- Labeler
- Asclemed USA, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076416
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76420-338 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76420-338-00 | 76420033800 | 1000 TABLET in 1 BOTTLE (76420-338-00) |
| 76420-338-15 | 76420033815 | 150 TABLET in 1 BOTTLE (76420-338-15) |
| 76420-338-30 | 76420033830 | 30 TABLET in 1 BOTTLE (76420-338-30) |
| 76420-338-60 | 76420033860 | 60 TABLET in 1 BOTTLE (76420-338-60) |
| 76420-338-90 | 76420033890 | 90 TABLET in 1 BOTTLE (76420-338-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2f460275-565f-4737-a3df-bf80b9acc268
Use it
Look up 76420-338 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76420-338 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76420-338. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.